| Design Therapeutics, Inc. DSGN | $20.28M | 8.91 | 5.03M | 0% | +$0 | 2.18 | |
| Olema Pharmaceuticals, Inc. OLMA | $49.63M | 7.84 | 4.38M | 0% | +$0 | 5.33 | |
| Adverum Biotechnologies, Inc. ADVM | $21.21M | 7.23 | 1.5M | New | +$21.21M | 2.28 | |
| NextCure, Inc. NXTC | $4.29M | 6.88 | 1.93M | New | +$4.29M | 0.46 | |
Cybin Inc. CYBN | $16.54M | 5.38 | 40M | New | +$16.54M | 1.78 | |
aTyr Pharma, Inc. LIFE | $6.04M | 4.49 | 3.1M | -47.01% | -$5.36M | 0.65 | |
| Ocular Therapeutix, Inc. OCUL | $51.99M | 3.75 | 5.81M | +45.29% | +$16.21M | 5.58 | |
Enliven Therapeutics, Inc. ELVN | $26.41M | 3.35 | 1.57M | +412.65% | +$21.26M | 2.84 | |
| Lineage Cell Therapeutics, Inc. LCTX | $9.25M | 3.31 | 6.25M | New | +$9.25M | 0.99 | |
| Annexon, Inc. ANNX | $21.87M | 3.3 | 3.05M | -38.38% | -$13.62M | 2.35 | |
| Allakos Inc. ALLK | $3.65M | 3.28 | 2.9M | 0% | +$0 | 0.39 | |
Silence Therapeutics plc SLN | $31.09M | 3.16 | 1.48M | +269.01% | +$22.66M | 3.34 | |
| Trevi Therapeutics, Inc. TRVI | $7.59M | 3.12 | 2.2M | New | +$7.59M | 0.82 | |
| Astria Therapeutics, Inc. ATXS | $17.52M | 2.27 | 1.24M | +128.45% | +$9.85M | 1.88 | |
| IDEAYA Biosciences, Inc. IDYA | $65.82M | 1.98 | 1.5M | -16.67% | -$13.16M | 7.07 | |
| Elevation Oncology, Inc. ELEV | $5.13M | 1.83 | 1M | New | +$5.13M | 0.55 | |
Immunocore Holdings plc IMCR | $58.5M | 1.8 | 900,000 | +125% | +$32.5M | 6.28 | |
Dyne Therapeutics, Inc. DYN | $49.11M | 1.77 | 1.73M | -7.98% | -$4.26M | 5.27 | |
| Structure Therapeutics Inc. GPCR | $30.86M | 1.54 | 720,058 | -32.71% | -$15M | 3.31 | |
| Geron Corporation GERN | $29.7M | 1.52 | 9M | New | +$29.7M | 3.19 | |
| Rocket Pharmaceuticals, Inc. RCKT | $35.02M | 1.43 | 1.3M | +1.96% | +$673,500.00 | 3.76 | |
| Immunovant, Inc. IMVT | $57.35M | 1.22 | 1.77M | +47.92% | +$18.58M | 6.16 | |
| Cullinan Oncology, Inc. CGEM | $11.93M | 1.22 | 700,000 | New | +$11.93M | 1.28 | |
| Applied Therapeutics, Inc. APLT | $8.98M | 1.18 | 1.35M | -18.68% | -$2.06M | 0.96 | |
Kyverna Therapeutics, Inc. Common Stock KYTX | $12.42M | 1.16 | 500,000 | New | +$12.42M | 1.33 | |
| Akero Therapeutics, Inc. AKRO | $20.21M | 1.16 | 800,000 | 0% | +$0 | 2.17 | |
| Viridian Therapeutics, Inc. VRDN | $12.26M | 1.1 | 700,000 | +16.67% | +$1.75M | 1.32 | |
| Xencor, Inc. XNCR | $14.38M | 1.05 | 650,000 | New | +$14.38M | 1.54 | |
| Vera Therapeutics, Inc. VERA | $24.79M | 1.05 | 575,000 | New | +$24.79M | 2.66 | |
| Celldex Therapeutics, Inc. CLDX | $27.28M | 0.99 | 650,000 | New | +$27.28M | 2.93 | |
Immatics N.V. IMTX | $10.51M | 0.97 | 1M | New | +$10.51M | 1.13 | |
| Praxis Precision Medicines, Inc. PRAX | $9.15M | 0.88 | 150,000 | New | +$9.15M | 0.98 | |
| IO Biotech, Inc. IOBT | $854,321.00 | 0.75 | 493,827 | 0% | +$0 | 0.09 | |
| Apellis Pharmaceuticals, Inc. APLS | $47.02M | 0.66 | 800,000 | -15.79% | -$8.82M | 5.05 | |
Spyre Therapeutics, Inc. SYRE | $9.48M | 0.62 | 250,000 | +66.67% | +$3.79M | 1.02 | |
| Immunic, Inc. IMUX | $555,963.00 | 0.47 | 421,184 | 0% | +$0 | 0.06 | |
CG Oncology, Inc. Common stock CGON | $13.17M | 0.45 | 300,000 | New | +$13.17M | 1.41 | |
| Sarepta Therapeutics, Inc. SRPT | $51.78M | 0.42 | 400,000 | New | +$51.78M | 5.56 | |
| Syndax Pharmaceuticals, Inc. SNDX | $8.33M | 0.41 | 350,000 | New | +$8.33M | 0.89 | |
| Kura Oncology, Inc. KURA | $6.4M | 0.39 | 300,000 | New | +$6.4M | 0.69 | |
Tourmaline Bio, Inc. TRML | $2.27M | 0.39 | 99,208 | -65.11% | -$4.24M | 0.24 | |
| COMPASS Pathways plc CMPS | $1.81M | 0.38 | 257,980 | -48.4% | -$1.7M | 0.2 | |
| Janux Therapeutics, Inc. JANX | $5.65M | 0.29 | 150,000 | New | +$5.65M | 0.61 | |
Neumora Therapeutics, Inc. Common Stock NMRA | $6.19M | 0.24 | 382,345 | 0% | +$0 | 0.67 | |
| Leap Therapeutics, Inc. LPTX | $105,070.00 | 0.1 | 39,500 | New | +$105,070.00 | 0.01 | |
| Cytokinetics, Incorporated CYTK | $7.01M | 0.09 | 100,000 | -93.85% | -$106.92M | 0.75 |